Stay updated on Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial

Sign up to get notified when there's something new on the Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now shows the site software revision version as v3.5.3 instead of v3.5.2, indicating an update to the ClinicalTrials.gov interface/system rather than the underlying study record.
    Difference
    0.0%
    Check dated 2026-04-24T06:33:31.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    On 2026-04-13 a new page revision (v3.5.2) was added with a Study Status entry (ID 434). The older revision (v3.5.0) was removed.
    Difference
    0.1%
    Check dated 2026-04-17T02:51:50.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    New version entries dated 2026-04-04 to 2026-04-09 include Study Status updates in the record history.
    Difference
    0.2%
    Check dated 2026-04-09T21:48:37.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    New record versions 424–428 dated 2026-03-26 to 2026-04-02 have been added, including Study Status updates in the history.
    Difference
    0.2%
    Check dated 2026-04-02T15:42:35.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    New history entries were added for Study Status on 2026-03-25 and earlier dates (versions 422–418), updating the record's status timeline.
    Difference
    0.2%
    Check dated 2026-03-26T11:44:50.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Added Study Status entries with current status updates and updated revision information (Revision: v3.5.0) on the history page. Removed Revision: v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-19T05:25:28.000Z thumbnail image

Stay in the know with updates to Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Comparison of Pembrolizumab Timing in High-Risk Melanoma Clinical Trial page.